Complementary roles of β-catenin and glutamine synthetase immunostaining in diagnosis of chemotherapy-treated and untreated hepatoblastoma

Stocker, 2001, Hepatic tumors in children, Clin Liver Dis, 5, 259, 10.1016/S1089-3261(05)70163-X Stiller, 1996, Geographic and ethnic variations in the incidence of childhood cancer, Br Med Bull, 52, 682, 10.1093/oxfordjournals.bmb.a011577 Spector, 2012, The epidemiology of hepatoblastoma, Pediatr Blood Cancer, 59, 776, 10.1002/pbc.24215 Chang, 2014, Pathogenesis of virus-associated human cancers: Epstein-Barr virus and hepatitis B virus as two examples, J Formos Med Assoc, 113, 581, 10.1016/j.jfma.2013.09.001 Aronson, 2005, Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study, J Clin Oncol, 23, 1245, 10.1200/JCO.2005.07.145 Schnater, 2002, Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group, Cancer, 94, 1111, 10.1002/cncr.10282 Malek, 2010, Review of outcomes of primary liver cancers in children: our institutional experience with resection and transplantation, Surgery, 148, 778, 10.1016/j.surg.2010.07.021 Wang, 2010, Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study, Am J Surg Pathol, 34, 287, 10.1097/PAS.0b013e3181ce5f1e Saxena, 1993, Chemotherapy effects on hepatoblastoma. A histological study, Am J Surg Pathol, 17, 1266, 10.1097/00000478-199312000-00008 Jeng, 2000, Somatic mutations of β-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma, Cancer Lett, 152, 45, 10.1016/S0304-3835(99)00433-4 Wei, 2000, Activation of β-catenin in epithelial and mesenchymal hepatoblastomas, Oncogene, 19, 498, 10.1038/sj.onc.1203356 Yamaoka, 2006, Diagnostic and prognostic impact of β-catenin alterations in pediatric liver tumors, Oncol Rep, 15, 551 Behrens, 1996, Functional interaction of β-catenin with the transcription factor LEF-1, Nature, 382, 638, 10.1038/382638a0 Cadoret, 2002, New targets of β-catenin signaling in the liver are involved in the glutamine metabolism, Oncogene, 21, 8293, 10.1038/sj.onc.1206118 Shafizadeh, 2011, Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques, Adv Anat Pathol, 18, 438, 10.1097/PAP.0b013e318234abb4 Bioulac-Sage, 2009, Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology, Liver Int, 29, 459, 10.1111/j.1478-3231.2008.01849.x Bioulac-Sage, 2007, Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry, Hepatology, 46, 740, 10.1002/hep.21743 Schmidt, 2011, Differential expression of glutamine synthetase and cytochrome P450 isoforms in human hepatoblastoma, Toxicology, 281, 7, 10.1016/j.tox.2011.01.006 Ranganathan, 2005, β-catenin and met deregulation in childhood hepatoblastomas, Pediatr Dev Pathol, 8, 435, 10.1007/s10024-005-0028-5 Vermeulen, 2010, Wnt activity defines colon cancer stem cells and is regulated by the microenvironment, Nat Cell Biol, 12, 468, 10.1038/ncb2048 Baldus, 2004, MUC1 and nuclear β-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis, Clin Cancer Res, 10, 2790, 10.1158/1078-0432.CCR-03-0163 Chen, 2002, P53 gene and Wnt signaling in benign neoplasms: β-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia, Hepatology, 36, 927, 10.1053/jhep.2002.36126